Skip to content

Tele Health Monitoring Service for Patients With Chronic Obstructive Pulmonary Disease

Tele Health Monitoring Service for Patients With Chronic Obstructive Pulmonary Disease. A Clinical, Randomized, Controlled Study for Evaluation of Clinical and Economic Consequences of Monitoring Service

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02615795
Enrollment
160
Registered
2015-11-26
Start date
2011-03-31
Completion date
2018-06-06
Last updated
2019-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, COPD

Brief summary

The aim of this study is to evaluate the effect of monitoring patients with chronic obstructive pulmonary disease (COPD) after a hospitalization for COPD exacerbation or pneumonia. The patients are randomized to receive either standard treatment and follow up, or standard treatment and follow up, plus tele monitoring of key clinical parameters and symptoms for six months.

Detailed description

Telemedicine is a relatively new approach for the management of chronic obstructive pulmonary disease (COPD) disease. Telemedicine, for monitoring disease exacerbation, is the focus area of our research. The patient monitoring offers the possibility of early initiation of treatment of patients who has evidence of COPD exacerbation or pulmonary infection. The self-monitoring of potential exacerbation is started after a hospitalization, and is done by the patient on a daily (not on weekends) basis initially. After one month the monitoring is made at least three times weekly during the rest of the intervention period of six months. With the help of the monitoring equipment, the patient answers a short series of health related questions, and makes simple measurements of oxygen saturation, heart rate, lung function and weight. Data is sent to the hospital, and here the staff can assess the data and respond to them the same day, with a phone call to the patient, if the patient's condition has changed. The selected telemonitoring-equipment, consists of a monitoring systems for the assessment of key clinical parameters and symptoms. All patients, in the intervention group as well as in the control group, are trained in the use of a standardized self-treatment plan. It is expected that the monitoring of symptoms and signs will support patient empowerment. The investigation is planned to assess the clinical and economic effects of the intervention.

Interventions

DEVICETele Monitoring, using Tunstall monitoring device

Monitoring of symptoms and physiological parameters at home, using Tunstall Healthcare telemedicine equipment. Patients perform physiological measurement. In addition, they correspond to a standardized questionnaire regarding disease specific symptoms. Data is assessed by the medical staff the same day. If the data indicates worsening in the patient's condition, the patient is contacted by phone. The assessment of the patient is made either on the specialist nurse level, or at a conference between the specialist nurse and a senior pulmonary doctor. There is no call center service.

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic Obstructive Pulmonary Disease COPD with FEV1/FVC (Forced Expiratory Volume in 1 second / Forced Vital Capacity) below 70% at all times during the study. FEV1 below 51% during inclusion and during the further study. Inclusion takes place during a hospitalization, with exacerbation in pulmonary symptoms.

Exclusion criteria

* Not able to give written or oral consent * Terminal disease, such as cancer * Unstable heart disease, such as coronary infarction within the last to month * Disabling psychiatric disease * Asthma * Inability to use the equipment * Severe language barriers * Drug abuse * Alcohol abuse

Design outcomes

Primary

MeasureTime frame
Number of hospitalization daysDuring twelve months

Secondary

MeasureTime frameDescription
Number of hospitalizations caused by COPD exacerbationDuring twelve months
Number of COPD related contacts to emergency roomsTwelve months
Number of self-addressed COPD exacerbationsTwelve monthsWithout primary contact to medical staff
Sensitivity of physiological measurements in detecting COPD exacerbationDuring six months of interventionRelation between physiological measurements and COPD exacerbation
Duration of COPD related hospitalizations, in daysTwelve months
Health related quality of lifeTwelve monthsSaint George´s respiratory questionnaire, Hospital Anxiety and Depression score, SF-36 questionnaire
Number of all cause contacts to primary health sectorTwelve monthsContacts to general practitioner or Doctor on call in the primary health sector
MortalityDuring twelve months
Number of unplanned contact to primary health sectorTwelve monthsContacts to general practitioner or Doctor on call in the primary health sector

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026